Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nasrin Amiri-Dashatan, Mehdi Koushki, Hossein Hosseini, Hadi Khodabandehloo, Mjtaba Fathi, Amir Hossein Doustimotlagh & Mostafa Rezaei-Tavirani. (2022) Association between circulating visfatin and pre-eclampsia: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 35:13, pages 2606-2618.
Read now
Read now
Cahit Birdir, Janina Fryze, Stefanie Frölich, Markus Schmidt, Angela Köninger, Rainer Kimmig, Börge Schmidt & Alexandra Gellhaus. (2017) Impact of maternal serum levels of Visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11–13 weeks gestation on small for gestational age births. The Journal of Maternal-Fetal & Neonatal Medicine 30:6, pages 629-634.
Read now
Read now
E. Zorba, D. Vavilis, C. A. Venetis, V. Zournatzi, D. Kellartzis & B. C. Tarlatzis. (2012) Visfatin serum levels are increased in women with preeclampsia: A case-control study. The Journal of Maternal-Fetal & Neonatal Medicine 25:9, pages 1668-1673.
Read now
Read now
Shali Mazaki-Tovi, Roberto Romero, Sun Kwon Kim, Edi Vaisbuch, Juan Pedro Kusanovic, Offer Erez, Tinnakorn Chaiworapongsa, Francesca Gotsch, Pooja Mittal, Chia-Ling Nhan-Chang, Nandor Gabor Than, Ricardo Gomez, Jyh Kae Nien, Samuel S. Edwin, Percy Pacora, Lami Yeo & Sonia S. Hassan. (2010) Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?. The Journal of Maternal-Fetal & Neonatal Medicine 23:8, pages 857-868.
Read now
Read now
Articles from other publishers (30)
Khadijeh Nasri, Mona Mehrabi, Mojtaba Bayani & Amir Almasi-Hashiani. (2023) Maternal saliva visfatin level in term and preterm labor: A case control study. PLOS ONE 18:7, pages e0288786.
Crossref
Crossref
Lazarus Ugochukwu Okafor, George Uchenna Eleje, Joseph Ifeanyichukwu Ikechebelu, Emmanuel Onyebuchi Ugwu, Obi Betrand Nwosu, Okechukwu Christian Ikpeze, Gerald Okanandu Udigwe, Ahizechukwu Chigoziem Eke, Samuel A Okoli, Charlotte Blanche Oguejiofor, Chukwudi Anthony Ogabido, Divinefavour Echezona Malachy, Ifeanyichukwu Jude Ofor & Chigozie Geoffrey Okafor. (2023) Maternal and umbilical cord blood levels of leptin in pre-eclamptic and healthy pregnant women: A comparative cross-sectional study. Women's Health 19.
Crossref
Crossref
Soner Gök, Berfin Can Gök & Yaşar Enli. (2022) Evaluation of the adipokine levels of pregnant women with preeclampsia. Journal of Obstetrics and Gynaecology Research 49:1, pages 154-163.
Crossref
Crossref
Masood Sayadi Shahraki, Mohsen Mahmoudieh, Behrouz Kalidari, Hamid Melali, Maryam Mousavi, MohammadRaisi Ghourban Abadi, SeyedHossein Mirhosseini & SeyedAli Mirhosseini Dehabadi. (2022) Bone health after bariatric surgery: Consequences, prevention, and treatment. Advanced Biomedical Research 11:1, pages 92.
Crossref
Crossref
Anna Maria Nuzzo, Domenica Giuffrida, Laura Moretti, Paola Re, Giorgio Grassi, Guido Menato & Alessandro Rolfo. (2021) Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus. Scientific Reports 11:1.
Crossref
Crossref
Anna Wnuk, Aleksandra Stangret, Mateusz Wątroba, Anna E. Płatek, Marta Skoda, Krzysztof Cendrowski, Włodzimierz Sawicki & Dariusz Szukiewicz. (2020) Can adipokine visfatin be a novel marker of pregnancy‐related disorders in women with obesity?. Obesity Reviews 21:7.
Crossref
Crossref
Georgios Daskalakis, Ioannis Bellos, Melina Nikolakea, Vasilios Pergialiotis, Angeliki Papapanagiotou & Dimitrios Loutradis. (2020) The role of serum adipokine levels in preeclampsia: A systematic review. Metabolism 106, pages 154172.
Crossref
Crossref
Maria Portelli & Byron Baron. 2019. Prediction of Maternal and Fetal Syndrome of Preeclampsia. Prediction of Maternal and Fetal Syndrome of Preeclampsia.
Anthony Estienne, Alice Bongrani, Maxime Reverchon, Christelle Ramé, Pierre-Henri Ducluzeau, Pascal Froment & Joëlle Dupont. (2019) Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models. International Journal of Molecular Sciences 20:18, pages 4431.
Crossref
Crossref
M R Luizon, A C T Palei, V A Belo, L M Amaral, R Lacchini, G Duarte, R C Cavalli, V C Sandrim & J E Tanus-Santos. (2016) Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal 17:5, pages 427-434.
Crossref
Crossref
Autumn J. Broady, Matthew H. Loichinger, Hyeong Jun Ahn, Philip M.C. Davy, Richard C. Allsopp & Gillian D. Bryant-Greenwood. (2017) Protective proteins and telomere length in placentas from patients with pre-eclampsia in the last trimester of gestation. Placenta 50, pages 44-52.
Crossref
Crossref
Douglas B. Kell & Louise C. Kenny. (2016) A Dormant Microbial Component in the Development of Preeclampsia. Frontiers in Medicine 3.
Crossref
Crossref
M.S. El Shemi, M.H. Mohamed, A.O. AbdelRahman, H. Abdel Al & N.M. Ramadan. (2016) Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life. Journal of Neonatal-Perinatal Medicine 9:1, pages 73-82.
Crossref
Crossref
Mohamed Abdelaziz Youssry, Mohamed Amin Gabreel & Tabarak Ahmed Patel. (2016) Changes in Maternal Serum Leptin Levels during Pregnancy and after Labor in Preeclampsia, and Its Correlation to Neonatal Cord Leptin. Open Journal of Obstetrics and Gynecology 06:10, pages 588-600.
Crossref
Crossref
Mariana A. Costa. (2016) The endocrine function of human placenta: an overview. Reproductive BioMedicine Online 32:1, pages 14-43.
Crossref
Crossref
Ana C. Palei, Frank T. Spradley & Joey P. Granger. (2015) Chronic hyperleptinemia results in the development of hypertension in pregnant rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 308:10, pages R855-R861.
Crossref
Crossref
Marcelo R Luizon, Vanessa A Belo, Ana CT Palei, Lorena M Amaral, Riccardo Lacchini, Valeria C Sandrim, Geraldo Duarte, Ricardo C Cavalli & Jose E Tanus-Santos. (2015) Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy. Hypertension Research 38:5, pages 361-366.
Crossref
Crossref
Sadaf Mumtaz, Seham AlSaif, Susan Wray & Karen Noble. (2015) Inhibitory effect of visfatin and leptin on human and rat myometrial contractility. Life Sciences 125, pages 57-62.
Crossref
Crossref
Silvia Ferrero, Edurne Mazarico, Carme Valls, Silvana Di Gregorio, Rocío Montejo, Lourdes Ibáñez & M. Dolores Gomez-Roig. (2015) Relationship between Foetal Growth Restriction and Maternal Nutrition Status Measured by Dual-Energy X-Ray Absorptiometry, Leptin, and Insulin-Like Growth Factor. Gynecologic and Obstetric Investigation 80:1, pages 54-59.
Crossref
Crossref
M.S. Weedon-Fekjær, Y. Sheng, M. Sugulle, G.M. Johnsen, F. Herse, C.W. Redman, R. Lyle, R. Dechend & A.C. Staff. (2014) Placental miR-1301 is dysregulated in early-onset preeclampsia and inversely correlated with maternal circulating leptin. Placenta 35:9, pages 709-717.
Crossref
Crossref
Saeedeh Salimi, Farzaneh Farajian-Mashhadi, Anoosh Naghavi, Mojgan Mokhtari, Mahnaz Shahrakipour, Mohsen Saravani & Minoo Yaghmaei. (2014) Different Profile of Serum Leptin between Early Onset and Late Onset Preeclampsia. Disease Markers 2014, pages 1-7.
Crossref
Crossref
SHALI MAZAKI-TOVI, EDI VAISBUCH & ROBERTO ROMERO. (2014) ADIPOKINES AND PATHOPHYSIOLOGY OF PREGNANCY COMPLICATIONS – THE ROLE OF LEPTIN AND ADIPONECTIN. Fetal and Maternal Medicine Review 24:4, pages 232-259.
Crossref
Crossref
Monal R. Shroff, Claudia Holzman, Yan Tian, Rhobert W. Evans & Alla Sikorskii. (2013) Mid‐pregnancy maternal leptin levels, birthweight for gestational age and preterm delivery. Clinical Endocrinology 78:4, pages 607-613.
Crossref
Crossref
A F A Ferreira, J C Rezende, R de Cassia C. Oliveira, R Akolekar & K H Nicolaides. (2012) Maternal serum visfatin at 11–13 weeks’ gestation in preeclampsia. Journal of Human Hypertension 27:4, pages 261-264.
Crossref
Crossref
Aleksandra Stupak & Anna Kwaśniewska. (2012) Recent advances in diagnostics of preeclampsia in pregnancy. Zdrowie Publiczne 122:3, pages 316-321.
Crossref
Crossref
Kyoung-Hwa Choi, Bo-Sun Joo, Sheng-Ta Sun, Min-Jung Park, Jung-Bin Son, Jong-Kil Joo & Kyu-Sup Lee. (2012) Administration of visfatin during superovulation improves developmental competency of oocytes and fertility potential in aged female mice. Fertility and Sterility 97:5, pages 1234-1241.e3.
Crossref
Crossref
Seung-Chul Kim, Min Jung Park, Bo-Sun Joo, Jong-Kil Joo, Dong-Soo Suh & Kyu-Sup Lee. (2012) Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia. Journal of Obstetrics and Gynaecology Research 38:4, pages 665-673.
Crossref
Crossref
Konstanze Miehle, Holger Stepan & Mathias Fasshauer. (2011) Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre‐eclampsia. Clinical Endocrinology 76:1, pages 2-11.
Crossref
Crossref
Andrea L. Tranquilli & Beatrice Landi. (2010) The origin of pre-eclampsia: From decidual “hyperoxia” to late hypoxia. Medical Hypotheses 75:1, pages 38-46.
Crossref
Crossref
Shali Mazaki‐Tovi, Edi Vaisbuch, Roberto Romero, Juan Pedro Kusanovic, Tinnakorn Chaiworapongsa, Sun Kwon Kim, Chia‐Ling Nhan‐Chang, Ricardo Gomez, Bo H. Yoon, Lami Yeo, Pooja Mittal, Giovanna Ogge, Juan M. Gonzalez & Sonia S. Hassan. (2010) ORIGINAL ARTICLE: Maternal Plasma Concentration of the Pro‐Inflammatory Adipokine Pre‐B‐Cell‐Enhancing Factor (PBEF)/Visfatin Is Elevated In Pregnant Patients with Acute Pyelonephritis. American Journal of Reproductive Immunology 63:3, pages 252-262.
Crossref
Crossref